SCHEMBL21836672

SCHEMBL21836672

CCc1nn2c(c1C(=O)c1ccc(O)cc1)CCCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ THRB P10828 1/20 0.37
▸ TGFBR1 P36897 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ESR1 P03372 4/20 0.36
▸ ESR2 Q92731 4/20 0.36
▸ MAPT P10636 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SLC22A12 Q96S37 3/20 0.35
▸ EYA3 Q99504 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24288747 0.81 SLC22A12 (0.38) SLC6A3THRBMAPK14ALDH1A1KMT2A
SCHEMBL24173026 0.78 PRMT1 (0.33) —
SCHEMBL24288760 0.76 SLC22A12 (0.34) SLC6A3THRBMAPK14ALDH1A1GAA
SCHEMBL24173221 0.74 PRMT1 (0.35) —
SCHEMBL21836679 0.71 MAPK1 (0.47) SLC6A2SLC6A3KMT2AMAPTLMNA
SCHEMBL31053394 0.68 HCAR2 (0.35) ALDH1A1GAAALOX15KMT2AHRH3
SCHEMBL31053388 0.67 ALDH1A1 (0.42) ALDH1A1GAAALOX15KMT2AMEN1
SCHEMBL20181600 0.66 MIF (0.43) ALDH1A1GAAALOX15KMT2AMEN1
SCHEMBL8877953 0.65 RARB (0.44) ALDH1A1KMT2AMEN1MAPT
SCHEMBL24592873 0.64 SLC22A12 (0.38) ALDH1A1ESR1ESR2MAPTSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11597725-B2 URAT1 inhibitor for promoting uric acid excretion JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) 2023-03-07 — — US disclosed
CN-108484600-B URAT1 inhibitors for promoting uric acid excretion 江苏新元素医药科技有限公司 2022-12-13 — — CN disclosed
EP-3632904-B1 URAT1 INHIBITORS FOR PROMOTING URIC ACID EXCRETION JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD (CN) 2022-04-20 — — EP disclosed
EP-3632904-B1 URAT1 INHIBITORS FOR PROMOTING URIC ACID EXCRETION JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD (CN) 2022-04-20 — — EP disclosed
US-20200262832-A1 URAT1 INHIBITOR FOR PROMOTING URIC ACID EXCRETION JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) 2020-08-20 — — US disclosed
EP-3632904-A1 URAT1 INHIBITOR FOR PROMOTING URIC ACID EXCRETION Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. (CN) 2020-04-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597725-B2 URAT1 inhibitor for promoting uric acid excretion SLC10A6, SLC10A1, SLC28A1 SLC6A2 109/4885SLC6A3 168/4885THRB 1992/4885
US-20200262832-A1 URAT1 INHIBITOR FOR PROMOTING URIC ACID EXCRETION SLC10A6, SLC10A1, SLC28A1 SLC6A2 109/4885SLC6A3 168/4885THRB 1992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback